3RD INTERNATIONAL OSTEOPOROSIS FOUNDATION MIDDLE EAST and AFRICA OSTEOPOROSIS MEETING
Abu Dhabi National Exhibition Centre *Abu Dhabi, UAE
The International Osteoporosis Foundation (IOF) and the Emirates Osteoporosis Society (EOS) look forward to welcoming you to Abu Dhabi for the IOF Regionals 3rd Middle East and Africa Osteoporosis Meeting taking place at the Abu Dhabi National Exhibitions Center (ADNEC) from December 5-7, 2015.
The Meeting is the leading educational and research forum for osteoporosis and related diseases in the region. It’s an ideal opportunity to learn about new clinical advances and to hear about the latest regional research.
New! A pre-meeting workshop Diabetes & Osteoporosis: the new frontier will be held. More details to follow.
For the first time, the meeting will be opened by a dedicated half-day workshop on the topic ofBone and Diabetes, two interrelated issues of great importance, particularly in the Middle-East. The workshop will involve a number of expert speakers from the fields of bone and musculoskeletal health. It will address key points such as the increased risk of osteoporosis in people with diabetes, the impact of new diabetes therapies on bone health and the safety and efficacy of osteoporosis therapies in people with diabetes.
Join key international experts and clinicians from throughout the region at this important educational and scientific event.
In Plenary, Oral Communication & Meet-the-Expert sessions – with direct clinical relevance for a broad audience
- Major health problems in the Middle East and their link to bone
- What’s new on the horizon in therapy
- Orthopaedics /Fracture
- Skeletal rare diseases
- Men and Bone Health
- Vitamin D and pregnancy/ lactation
- Sequential/ combined therapies in osteoporosis
- Calcium supplements and cardiovascular risk
- Management of osteoporosis in frail elderly
- Treat to target
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
The Abu Dhabi National Exhibition Centre (ADNEC) is the largest exhibition venue in the Middle East. ADNEC provides interconnected flat-roofed indoor floor space of 73,000 m2. This iconic venue is fully equipped with modern state-of-the-art facilities and has been recognized as one of the most sustainable exhibition and conference venues in the world. It forms the hub of the vibrant Capital Gate development which includes a host of architecturally-advanced hotels and office buildings.
Abu Dhabi National Exhibition Centre (ADNEC)
Khaleej Al Arabi Street, P.O. Box 5546
Abu Dhabi; United Arab Emirates
Tel: +971 (0) 2 444 6900
Abstract submissions are invited for the IOF Regionals – 3rd Middle East and Africa Osteoporosis Meeting scientific programme. All abstracts will be published in a supplement of Osteoporosis International.
Deadline: August 14, 2015 (GMT + 4)
All abstracts for the Meeting must be submitted using the online abstract submission system – available Mai 18, 2015.
Submission by fax, e-mail or courier will not be accepted.
While delegates may indicate their preference for oral or poster presentation, the final decision is taken by the Scientific Programme Committee. While every attempt will be made to programme abstracts according to the requests of authors, oral presentations cannot be guaranteed.
All submitted abstract must contain original data in order for it to be published.
IOF is not responsible for errors in the abstract submission. Read your text to ensure accuracy with no spelling, grammatical or scientific errors. No corrections will be accepted after the abstract submission deadline.
IOF will not translate any abstract. It will be published if accepted as submitted in English in a supplement of Osteoporosis International.
Submission of an abstract constitutes a formal commitment by the presenting author to attend the Meeting and present the abstract (if accepted) orally or as a poster in the session and at the time assigned by the Scientific Programme Committee.
Expenses associated with the preparation, submission and presentation of an abstract are the responsibility of the presenting authors.
All submitting authors must consent to the Declaration Statement on behalf of her/his co-authors in order for the abstract to be accepted for submission. This includes the certification that any work with human or animal subjects related in this abstract complies with the guiding principles for experimental procedures as set forth in the Declaration of Helsinki and related publications.
Organisation and Content: Please read this information carefully
Abstracts will be published in a supplement of Osteoporosis International (only if accepted).
For standardisation, the total length of the abstract must not exceed 3000 printable characters (these include nonvisible characters such as spaces) and 50 line counts.
The body of the abstract will be structured as follows with the following subtitles:
References (if applicable)
Acknowledgments (if applicable)
Images may be included with the following criteria:
Minimum image resolution: 300 dpi
Maximum image width: 8 cm
Allowed file types: .gif, .jpg
Commercial (trade) names of drugs are not allowed – the generic or chemical names must be used.
Please be advised that the insertion of images may significantly reduce the number of remaining characters, because these will be included in the character and line count. It is highly recommended to use only one image file to allow for enough abstract text.
The abstract Title should clearly define the content of the paper.
It is preferable that the Aim is stated in one sentence, the Methods kept to a brief description, that the Results are summarised and presented in sufficient detail to support the Conclusions. Note that it is not recommended to postulate that “the results will be discussed during the oral presentation” or that “other data will be presented later”.
Images will be published in greyscale with a printed width of approximately 8 cm. An image should be large enough so that it is readable when printed in the abstract book.
Please refer to the online abstract submission platform for further details regarding abstract content and style, including submission of Greek characters. Note that copy-pasting is enabled with automatic update of the font style.
Use standard abbreviations where appropriate. Include any other abbreviations in brackets after the full word the first time it appears.
Number and list references (if applicable) in the order in which they appear in the abstract, within the 3000 characters limit.
All Acknowledgements to grants, funding source or other coworkers will appear at the bottom of the abstract and shall be included in the 3000 characters limit.
Sponsorship and Exhibition
INTERNATIONAL OSTEOPOROSIS FOUNDATION
Mario Fetz – Director of External Relations
T +41 22 994 0131
M +41 79 176 23 82